Display options
Share it on

Oncoimmunology. 2015 Jul 28;5(1):e1061175. doi: 10.1080/2162402X.2015.1061175. eCollection 2016.

CD11b+Ly6G+ cells inhibit tumor growth by suppressing IL-17 production at early stages of tumorigenesis.

Oncoimmunology

Yuhong Liu, Claire E O'Leary, Liang-Chuan S Wang, Tricia R Bhatti, Ning Dai, Veena Kapoor, Peihui Liu, Junjie Mei, Lei Guo, Paula M Oliver, Steven M Albelda, G Scott Worthen

Affiliations

  1. Division of Neonatology; Children's Hospital of Philadelphia ; Philadelphia, PA USA.
  2. Perelman School of Medicine; University of Pennsylvania ; Philadelphia, PA USA.
  3. Division of Pulmonary; Allergy and Critical Care Medicine; Department of Medicine; Perelman School of Medicine at the University of Pennsylvania ; Philadelphia, PA USA.
  4. Department of Pathology and Laboratory Medicine; Children's Hospital of Philadelphia ; Philadelphia, PA USA.
  5. Department of Pediatrics; Affiliated Shenzhen Maternity & Healthcare Hospital of Southern Medical University ; Shenzhen, China.
  6. Division of Neonatology; Children's Hospital of Philadelphia; Philadelphia, PA USA; Institute of Medical Biology; Chinese Academy of Medical Sciences; Peking Union Medical College; Kunming, Yunnan Province, P. R. China.
  7. Institute of Medical Biology; Chinese Academy of Medical Sciences; Peking Union Medical College ; Kunming, Yunnan Province, P. R. China.
  8. Perelman School of Medicine; University of Pennsylvania; Philadelphia, PA USA; Cell Pathology Division; Department of Pathology and Laboratory Medicine; Children's Hospital of Philadelphia; Philadelphia, PA USA.
  9. Division of Neonatology; Children's Hospital of Philadelphia; Philadelphia, PA USA; Department of Pediatrics; Perelman School of Medicine; University of Pennsylvania; Philadelphia, PA USA.

PMID: 26942073 PMCID: PMC4760327 DOI: 10.1080/2162402X.2015.1061175

Abstract

Neutrophils are important innate immune cells involved in microbial clearance at the sites of infection. However, their role in cancer development is unclear. We hypothesized that neutrophils mediate antitumor effects in early tumorigenesis. To test this, we first studied the cytotoxic effects of neutrophils

Keywords: CD11b+Ly6G+Cells, Neutrophils, Tumor, IL-17 and CD8+T cells

References

  1. Cancer Immunol Immunother. 2013 Nov;62(11):1745-56 - PubMed
  2. Nat Med. 2013 Jan;19(1):57-64 - PubMed
  3. Med Res Rev. 2011 May;31(3):311-63 - PubMed
  4. J Exp Med. 2001 Aug 20;194(4):519-27 - PubMed
  5. J Clin Invest. 2012 Mar;122(3):974-86 - PubMed
  6. J Leukoc Biol. 2011 Feb;89(2):311-7 - PubMed
  7. Nat Commun. 2011 Dec 20;2:600 - PubMed
  8. Crit Rev Oncol Hematol. 2012 Jun;82(3):296-309 - PubMed
  9. PLoS One. 2013;8(1):e53131 - PubMed
  10. Blood. 2001 Dec 1;98(12):3309-14 - PubMed
  11. Cancer Res. 2011 Apr 1;71(7):2411-6 - PubMed
  12. Contrib Microbiol. 2006;13:118-37 - PubMed
  13. Oncoimmunology. 2012 Oct 1;1(7):1161-1162 - PubMed
  14. PLoS One. 2011;6(11):e27690 - PubMed
  15. Carcinogenesis. 2012 May;33(5):949-55 - PubMed
  16. J Immunol. 2011 Jan 15;186(2):807-15 - PubMed
  17. Cancer Res. 2005 Dec 15;65(24):11752-61 - PubMed
  18. Clin Cancer Res. 2012 Oct 1;18(19):5212-23 - PubMed
  19. Science. 2011 Mar 25;331(6024):1565-70 - PubMed
  20. Cytokine Growth Factor Rev. 2005 Dec;16(6):593-609 - PubMed
  21. Cell Immunol. 2012;272(2):166-74 - PubMed
  22. Blood. 2001 Jan 15;97(2):339-45 - PubMed
  23. Head Neck. 2011 Sep;33(9):1301-8 - PubMed
  24. Biochem Biophys Res Commun. 2001 Apr 6;282(3):735-8 - PubMed
  25. PLoS One. 2012;7(2):e31524 - PubMed
  26. Nat Rev Immunol. 2009 Mar;9(3):162-74 - PubMed
  27. Cancer Res. 1996 Jan 1;56(1):21-6 - PubMed
  28. Cancer J. 2010 Jul-Aug;16(4):325-35 - PubMed
  29. J Immunol. 2011 Mar 1;186(5):3197-205 - PubMed
  30. J Leukoc Biol. 2009 Nov;86(5):1065-73 - PubMed
  31. J Immunol. 2012 Sep 1;189(5):2191-202 - PubMed
  32. PLoS One. 2012;7(7):e40677 - PubMed
  33. Cancer Cell. 2009 Sep 8;16(3):183-94 - PubMed
  34. Cancer Res. 2013 Nov 15;73(22):6609-20 - PubMed
  35. Proc Natl Acad Sci U S A. 1995 Jul 3;92(14):6254-8 - PubMed
  36. Cancer Cell. 2011 Sep 13;20(3):300-14 - PubMed
  37. J Leukoc Biol. 2008 Sep;84(3):623-30 - PubMed
  38. Cancer Res. 2009 Oct 1;69(19):7503-6 - PubMed
  39. Clin Cancer Res. 2013 Jul 1;19(13):3404-15 - PubMed
  40. J Immunol. 2006 Dec 1;177(11):8123-32 - PubMed
  41. J Immunol. 2004 Jan 15;172(2):989-99 - PubMed
  42. Cancer Lett. 2008 Aug 28;267(2):226-44 - PubMed
  43. Semin Immunopathol. 2013 Mar;35(2):163-76 - PubMed
  44. Trends Immunol. 2012 Oct;33(10):496-504 - PubMed
  45. J Clin Oncol. 2007 Apr 20;25(12):1562-9 - PubMed
  46. J Clin Oncol. 2009 Oct 1;27(28):4709-17 - PubMed
  47. Cancer Immunol Immunother. 2012 Aug;61(8):1155-67 - PubMed
  48. Oncoimmunology. 2012 Aug 1;1(5):783-785 - PubMed
  49. Cancer Res. 2013 Jun 15;73(12):3566-77 - PubMed
  50. Immunity. 2005 Mar;22(3):285-94 - PubMed
  51. J Immunol. 2010 Mar 1;184(5):2281-8 - PubMed
  52. J Immunol. 2004 Mar 1;172(5):2853-60 - PubMed
  53. Immunity. 2008 Apr;28(4):454-67 - PubMed

Publication Types